Jordan M. Cloyd
The Ohio State University Wexner Medical Center
CancerInternal medicineRadiologySurgeryOncologyResectionRetrospective cohort studyChemotherapyHepatectomyNeoadjuvant therapyPancreatectomyHyperthermic intraperitoneal chemotherapyMEDLINESurgical oncologyPancreatic cancerPerioperativeIncidence (epidemiology)General surgeryMedicineGastroenterology
294Publications
22H-index
2,376Citations
Publications 238
Newest
#1Alessandro Paro (The Ohio State University Wexner Medical Center)H-Index: 1
#2Djhenne Dalmacy (The Ohio State University Wexner Medical Center)H-Index: 4
Last. Timothy M. Pawlik (The Ohio State University Wexner Medical Center)H-Index: 121
view all 9 authors...
Abstract null null Background null Care patterns among patients diagnosed with pancreatic adenocarcinoma remain poorly defined. null null null Methods null Cluster analysis was performed on patients with pancreatic adenocarcinoma to assess time from diagnosis to death spent in different care settings (home self-care-dominant[HSC], acute in-hospital care-dominant[ACS], hospice care-dominant[HC] or mixed home and hospice care[MHH]). null null null Results null Among 32,816 patients, most belonged ...
Source
#1Anjuli K. Luthra (The Ohio State University Wexner Medical Center)H-Index: 3
#2Phil A. Hart (The Ohio State University Wexner Medical Center)H-Index: 29
Last. Darwin L. Conwell (The Ohio State University Wexner Medical Center)H-Index: 54
view all 11 authors...
Abstract null null Background and Aims null : EUS-guided needle-based confocal laser endomicroscopy (nCLE) improves the diagnostic accuracy of pancreatic cystic lesions (PCLs) but concerns regarding its expense have limited widespread adoption of this technology. We conducted a cost-benefit analysis to assess the healthcare resource implications of adding EUS-nCLE to the standard of care (SOC) management of PCLs. null null null Methods null : A post-hoc analysis of a prospective study (2015-2018...
Source
#6Timothy M. Pawlik (The Ohio State University Wexner Medical Center)H-Index: 121
#8Anne M. Noonan (The Ohio State University Wexner Medical Center)H-Index: 17
Source
#1Nikhil Sebastian (Emory University)H-Index: 1
#2Amy Webb (OSU: Ohio State University)H-Index: 12
Last. Wei Chen (OSU: Ohio State University)H-Index: 12
view all 16 authors...
Background: Optimal patient selection for radiotherapy in pancreatic ductal adenocarcinoma (PDAC) is unestablished. Molecular profiling may select patients at high risk for locoregional recurrence (LRR) who would benefit from radiation. Methods: We included resectable pancreatic cancer (R-PDAC) patients, divided into training and validation cohorts, treated among three institutions with surgery and adjuvant chemotherapy, and borderline resectable or locally advanced pancreatic cancer (BR/LA-PDAC...
Source
Source
#1Zachary J. Brown (The Ohio State University Wexner Medical Center)H-Index: 1
#2Hanna E Labiner (The Ohio State University Wexner Medical Center)H-Index: 2
Last. Jordan M. Cloyd (The Ohio State University Wexner Medical Center)H-Index: 22
view all 6 authors...
INTRODUCTION Neoadjuvant therapy (NT) is increasingly used for localized pancreatic ductal adenocarcinoma (PDAC). The impact of care fragmentation during NT on the outcomes of patients with PDAC is unknown. METHODS Adult patients with Stage I-III PDAC who received NT and patients who underwent surgery first followed by adjuvant therapy (AT) between 2004 and 2016 were queried from the National Cancer Database. Short- and long-term outcomes were compared between patients who received fragmented ca...
Source
Source
#1Marissa Guo (OSU: Ohio State University)
Last. Jordan M. CloydH-Index: 22
view all 4 authors...
Source
#1Wasay Nizam (Johns Hopkins University)H-Index: 3
#2Nadege Fackche (Johns Hopkins University)H-Index: 5
Last. Joel M. Baumgartner (UCSD: University of California, San Diego)H-Index: 22
view all 23 authors...
Tumor markers are commonly utilized in the diagnostic evaluation, treatment decision making, and surveillance of appendiceal tumors. In this study, we aimed to determine the prognostic significance of elevated preoperative tumor markers in patients with pseudomyxoma peritonei secondary to low-grade appendiceal mucinous neoplasm who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Using a multi-institutional database, eligible patients with measured preoperative tumo...
Source
#1Jason T Wiseman (St. Joseph's Hospital and Medical Center)
#2Carmen E. Quatman (The Ohio State University Wexner Medical Center)H-Index: 5
Last. Jordan M. Cloyd (The Ohio State University Wexner Medical Center)H-Index: 22
view all 3 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.